BioSpace News Archive

Vaccine Market Trend- High Focus on Developing and Increasing the Supply of COVID-19 Vaccine

Increasing prevalence of infectious diseases across the globe, rising need for effective vaccination against coronavirus, and growing investments for development of novel vaccines are some key factors expected to drive global Vaccine market.

June 7, 2022
·
6 min read
BioMidwest

Eight out of Ten Patients Maintained Skin Clearance at One Year in Lilly’s Lebrikizumab Atopic Dermatitis Monotherapy Trials

Eli Lilly and Company announced topline results from one-year analyses of the efficacy and safety of lebrikizumab, the company’s investigational IL-13 inhibitor for the treatment of patients with moderate-to-severe atopic dermatitis.

June 7, 2022
·
8 min read
Hepatitis C Market Insights by Size, Share and Forecast 2031

Wilmington, Delaware, United States: The growing inclination towards molecular diagnostics from conventional technologies has boosted all medical procedures to cut down dispatch time for results.

June 7, 2022
·
5 min read
ECG Telemetry Devices Market Analysis and Opportunity Assessment 2020-2030

Wilmington, Delaware, United States: Advancements in cardiovascular treatments have been at the forefront of growth within the global ECG telemetry devices market.

June 7, 2022
·
5 min read
Drug Development

Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refractory or recurrent (R/R) metastatic Triple Negative Breast Cancer

Genexine announced top-line results from the KEYNOTE-899 phase 1b/2 clinical trial of GX-I7 in combination with pembrolizumab.

June 7, 2022
·
5 min read
Pediatric Vaccines Market Share, Trends, Business Strategy and Forecast to 2030

Wilmington, Delaware, United States: Over the past two to three decades, considerable efforts have been made to develop and improve global health, particularly in underdeveloped and developing regions.

June 7, 2022
·
5 min read
Drug Development

Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting

Chordia Therapeutics Inc. announced that it has presented the interim results from the Phase 1 clinical trial of CTX-712, a selective pan-CDC-like kinase inhibitor discovered by Chordia, at the 2022 Annual Meeting of the American Society of Clinical Oncology, which was held from June 3 to June 7.

June 7, 2022
·
7 min read
BioMidwest

Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test

Biodesix, Inc. announced that WPS Government Health Administrators, the Medicare Administrative Contractor with jurisdiction for Biodesix’s De Soto, Kansas laboratory, has provided coverage for the Nodify CDT® lung nodule test.

June 7, 2022
·
5 min read
BioMidwest

Shin-Matsudo Central General Hospital Select’s ViewRay’s MRIdian® MRI-Guided Radiation Therapy System to Expand Access to Precision Radiation Therapy

ViewRay, Inc. announced that Shin-Matsudo Central General Hospital has purchased a MRIdian MRI-guided radiation therapy system for installation at Shin-Matsudo Accuracy Radiation Therapy Center in Japan.

June 7, 2022
·
6 min read
Pharm Country

Merck to Hold Investor Event to Highlight Oncology Portfolio and Pipeline

Merck, known as MSD outside the United States and Canada, will provide a detailed overview of the company’s oncology portfolio and pipeline at an investor event at the 2022 American Society for Clinical Oncology Annual Meeting in Chicago at 7 a.m. CT/8 a.m. ET.

June 7, 2022
·
53 min read